[go: up one dir, main page]

IN2012DN02064A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02064A
IN2012DN02064A IN2064DEN2012A IN2012DN02064A IN 2012DN02064 A IN2012DN02064 A IN 2012DN02064A IN 2064DEN2012 A IN2064DEN2012 A IN 2064DEN2012A IN 2012DN02064 A IN2012DN02064 A IN 2012DN02064A
Authority
IN
India
Prior art keywords
representing
cr2r3
crl
linker
bio
Prior art date
Application number
Inventor
Laurence Moine
Laurent Bedouet
Alexandre Laurent
Denis Labarre
Michel Wassef
Van Nga Nguyen
Original Assignee
Occlugel
Centre Nat Rech Scient
Univ Paris Sud 11
Assist Publ Hopitaux De Paris
Univ Paris Diderot Paris 7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Occlugel, Centre Nat Rech Scient, Univ Paris Sud 11, Assist Publ Hopitaux De Paris, Univ Paris Diderot Paris 7 filed Critical Occlugel
Publication of IN2012DN02064A publication Critical patent/IN2012DN02064A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06—Polymers provided for in subclass C08G
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06—Polymers provided for in subclass C08G
    • C08F290/061—Polyesters; Polycarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06—Polymers provided for in subclass C08G
    • C08F290/062—Polyethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L55/00—Compositions of homopolymers or copolymers, obtained by polymerisation reactions only involving carbon-to-carbon unsaturated bonds, not provided for in groups C08L23/00 - C08L53/00
    • C08L55/005—Homopolymers or copolymers obtained by polymerisation of macromolecular compounds terminated by a carbon-to-carbon double bond
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Graft Or Block Polymers (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

The present invention relates to a polymer obtained from the polymerization of: (i) at least one monomer of formula (I) (CH2=CRl)CO-K (I) wherein: K represents 0-Z or NH-Z, Z representing (CR2R3)m-CH3, (CH2-CH2-0)m-H, (CH2- CH2-0 )m-CH3, (CH2)m-N R4R5 with m representing an integer from 1 to 30; R1, R2, R3, R4 and R5 independently represent H or a C1 -C6 alkyl; and (ii) at least one bio-resorbable block copolymer cross-linker.
IN2064DEN2012 2009-09-10 2010-09-09 IN2012DN02064A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305830A EP2295480A1 (en) 2009-09-10 2009-09-10 Implantable bio-resorbable polymer
PCT/EP2010/063227 WO2011029867A1 (en) 2009-09-10 2010-09-09 Implantable bio-resorbable polymer
US24118310P 2010-09-10 2010-09-10

Publications (1)

Publication Number Publication Date
IN2012DN02064A true IN2012DN02064A (en) 2015-08-21

Family

ID=41531626

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2064DEN2012 IN2012DN02064A (en) 2009-09-10 2010-09-09

Country Status (13)

Country Link
US (1) US9320804B2 (en)
EP (2) EP2295480A1 (en)
JP (1) JP5792729B2 (en)
KR (1) KR101585588B1 (en)
CN (1) CN102597030B (en)
AU (1) AU2010294246B2 (en)
BR (1) BR112012005280B8 (en)
CA (1) CA2773499C (en)
ES (1) ES2472426T3 (en)
IN (1) IN2012DN02064A (en)
SG (1) SG179057A1 (en)
WO (1) WO2011029867A1 (en)
ZA (1) ZA201201752B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921429B2 (en) * 2010-11-23 2014-12-30 Howard University Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
EP2683750B1 (en) 2011-03-09 2017-04-19 Occlugel Implantable swellable bio-resorbable polymer
ES2601211T3 (en) 2011-03-09 2017-02-14 Occlugel Implantable bioabsorbable polymer loaded with fragile macromolecules
CN102304200B (en) * 2011-05-27 2013-08-21 中国海洋石油总公司 Crosslinked polymer microspheres and preparation method thereof
CN103709386B (en) * 2012-10-09 2016-03-30 上海微创医疗器械（集团）有限公司 Polydactyl acid biodegradable stent and preparation method thereof
CN103113533B (en) * 2013-02-01 2015-08-05 中国科学院长春应用化学研究所 Copolymer of poly lactic acid and preparation method thereof, polydactyl acid
CA2923741C (en) 2013-09-19 2022-06-07 Microvention, Inc. Polymer films
CN110279885B (en) * 2013-09-19 2022-07-26 泰尔茂株式会社 Polymer particles
KR102287781B1 (en) 2013-11-08 2021-08-06 테루모 가부시키가이샤 Polymer particles
CN105214145A (en) * 2014-06-23 2016-01-06 李茂全 The application of polylactic acid microsphere in hemorrhage
FR3024732B1 (en) * 2014-08-08 2016-08-12 Snf Sas HYDROSOLUBLE HYDROXYALKYL POLYMER OBTAINED BY INVERSE SUSPENSION POLYMERIZATION PROCESS OR REVERSE EMULSION
CN104558419B (en) * 2014-09-27 2017-07-11 温州大学 A kind of preparation method of environment sensitive type cyclodextrine derivatives hydrogel
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
AU2017214566A1 (en) 2016-02-05 2018-08-23 The General Hospital Corporation Drug eluting polymer composed of biodegradable polymers applied to surface of medical device
WO2017143277A1 (en) * 2016-02-17 2017-08-24 Biosphere Medical, Inc. Microspheres containing therapeutic agents and related methods of use
EP3475323B1 (en) * 2016-06-23 2024-12-11 The Regents of the University of Colorado, a body corporate Control of polymer network structures via nanogels
KR102174285B1 (en) 2016-09-28 2020-11-05 테루모 가부시키가이샤 Polymer particles
CN106543992A (en) * 2016-09-30 2017-03-29 成都西油华巍科技有限公司 A kind of polymer for drilling fluid microsphere sealing agent and preparation method thereof
EP3668491A4 (en) * 2017-08-16 2021-06-16 Biosphere Medical, Inc. Microspheres containing therapeutic agents and related methods of use
CN111150879B (en) * 2019-12-31 2022-06-17 华中科技大学鄂州工业技术研究院 Thrombus-promoting and X-ray developing suppository and preparation method and application thereof
WO2022047544A1 (en) * 2020-09-04 2022-03-10 IP Cornerstone Pty Ltd Minimally invasive treatment of osteoarthritis and other conditions
CN112934198B (en) * 2021-01-29 2022-07-08 浙江理工大学 A kind of cyclodextrin porous adsorption material and its preparation method and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0131112D0 (en) 2001-12-31 2002-02-13 Univ London Pharmacy Block copolymers
WO2005079856A1 (en) * 2004-02-23 2005-09-01 The University Of British Columbia Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules
JP2005330246A (en) * 2004-05-21 2005-12-02 Toray Ind Inc Pharmaceutical composition containing swelling hydrogel matrix
WO2006045183A1 (en) * 2004-10-25 2006-05-04 The University Of British Columbia Polymer barrier compositions for surgical wounds
CA2611985C (en) * 2005-06-17 2016-08-16 The University Of North Carolina At Chapel Hill Nanoparticle fabrication methods, systems, and materials
FI20060077L (en) * 2006-01-26 2007-07-27 Seppaelae Jukka Veli New biodegradable polymers
WO2009132206A1 (en) * 2008-04-25 2009-10-29 Liquidia Technologies, Inc. Compositions and methods for intracellular delivery and release of cargo
CN101265311A (en) * 2008-05-07 2008-09-17 天津大学 Preparation method of PVP-PEG-PLA shell cross-linked nano micelles

Also Published As

Publication number Publication date
CN102597030A (en) 2012-07-18
CN102597030B (en) 2013-11-06
BR112012005280A2 (en) 2020-10-27
AU2010294246A1 (en) 2012-04-05
CA2773499A1 (en) 2011-03-17
EP2475695B1 (en) 2014-04-02
EP2475695A1 (en) 2012-07-18
AU2010294246B2 (en) 2014-12-04
ZA201201752B (en) 2012-11-28
SG179057A1 (en) 2012-04-27
BR112012005280B8 (en) 2021-10-26
BR112012005280B1 (en) 2021-10-05
EP2295480A1 (en) 2011-03-16
WO2011029867A1 (en) 2011-03-17
US20120230937A1 (en) 2012-09-13
ES2472426T3 (en) 2014-07-01
KR20120099006A (en) 2012-09-06
JP5792729B2 (en) 2015-10-14
KR101585588B1 (en) 2016-01-14
JP2013504538A (en) 2013-02-07
CA2773499C (en) 2017-12-05
US9320804B2 (en) 2016-04-26

Similar Documents

Publication Publication Date Title
IN2012DN02064A (en)
MX2016008340A (en) Polyacrylonitrile (pan) polymers with low polydispersity index (pdi) and carbon fibers made therefrom.
MX336902B (en) Thickener containing a cationic polymer and softening composition containing said thickener, in particular for textiles.
WO2011025053A8 (en) Production method of copolymer of allyl monomer containing polar group
WO2012118681A3 (en) Silicone hydrogel contact lenses having acceptable levels of energy loss
TW200706594A (en) Biodegradable resin composition and molded article produced from the same
GB201316970D0 (en) Dimensionally stable silicone hydrogel contact lenses
WO2011090859A8 (en) Ethylene copolymers, methods for their production, and use
WO2008043529A3 (en) Wetting agents and dispersants based on mixtures of structured copolymers
MX2016000926A (en) Polymerisation initiators.
ATE393798T1 (en) FLAME-PROTECTED POLYAMIDE COMPOSITIONS USING ALUMINUM HYPOPHOSPHITE
MX348970B (en) Low density ethylene-based polymers with broad molecular weight distributions and low extractables.
SG168462A1 (en) Novel copolymer and photoresist composition comprising the same
MX338141B (en) Method for polymerising (meth)acrylic acid in solution, polymer solutions obtained and uses thereof.
MY159830A (en) Cyclic poly (phenylene ether ether ketone) composition and method for producing the same
MX2009013898A (en) Vulcanizable polymer compositions.
TW201129531A (en) Aromatic sulfonium salt compound
MX2009000113A (en) Method of producing a polymeric material, polymer, monomeric compound and method of preparing a monomeric compound.
MY160815A (en) Hydrosilicone resin and preparation process thereof
MX2021009427A (en) Primary amine-containing polymers useful as scale inhibitors.
TW200734294A (en) Polyarylene compound and process for producing the same
TW200641041A (en) Poly (hydroxy alkanoate) resin foamed particle
MY156771A (en) Novel copolymer
MY191206A (en) Acrylic acid polymers neutralized with sodium and calcium ions and having a narrow molecular weight distribution
MX2013009596A (en) Polymers on the basis of glycerin carbonate and an amine.